Status:

TERMINATED

Study of Mitomycin-C Application in Laryngotracheal Stenosis

Lead Sponsor:

University of California, San Francisco

Conditions:

Laryngeal Stenosis

Subglottic Stenosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of pati...

Detailed Description

Obstruction of the upper airway caused by laryngotracheal stenosis (LTS) often results in severe morbidity and even mortality. Treatment of LTS continues to present a challenge and a wide array of sur...

Eligibility Criteria

Inclusion

  • Patients with laryngotracheal stenosis, including subglottic stenosis or tracheal stenosis
  • Patients with disease amenable to treatment with endoscopic CO2 laser radial incisions and balloon dilation
  • Age greater than or equal to 18 years

Exclusion

  • Age less than 18 years
  • Pregnancy
  • Patients with glottic and supraglottic stenosis
  • Patients with disease not amenable to treatment with endoscopic CO2 laser radial incisions and balloon dilation
  • Patients with cartilaginous subglottic or tracheal stenosis

Key Trial Info

Start Date :

August 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2018

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01523275

Start Date

August 1 2012

End Date

February 1 2018

Last Update

May 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCSF - Voice and Swallowing Clinic

San Francisco, California, United States, 94115